Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN rides surging POC demand and global growth tailwinds, but U.S. channel shifts and macro risks may weigh on near-term performance.
Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?
Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Inogen (INGN) Up 6.8% Since Last Earnings Report: Can It Continue?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock?
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.41 per share a year ago.
Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
Inogen (INGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Inogen (INGN) Loses 10.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Inogen (INGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Here's Why You Should Add Inogen Stock to Your Portfolio Now
INGN looks poised as Q3 revenue rises 4%, POC demand grows and valuation is low, despite seasonal softness.
INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite
Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.
Here's Why You Should Add Inogen Stock to Your Portfolio Now
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
Here's Why You Should Add Inogen Stock to Your Portfolio Now
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
